Saroja Pharma Industries Complete Financial Statements
In FYNone, Saroja Pharma Industries (SAROJA) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 2.9% and ROE of 11.8%. Full financial statements from FY2021 to FY2026 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse SAROJA FII DII holdings to track promoter, FII and institutional holdings.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
SAROJA Revenue, Net Profit & EBITDA — Year-on-Year Growth
SAROJA YoY (March 2026 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. Also explore SAROJA share price charts to track price trends across different timeframes.
SAROJA Income Statement — Revenue, EBITDA & Net Profit
Saroja Pharma Industries revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 2.9%. For live price, earnings ratios and company overview, see SAROJA screener.
| Particulars | None | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 70 | 54 | 41 | 50 | 56 | 37 |
| Expenses | 0 | 66 | 51 | 38 | 48 | 54 | 35 |
| EBITDA | 0 | 4 | 3 | 3 | 3 | 2 | 1 |
| Operating Profit Margin % | 0.00% | 5.00% | 5.00% | 6.00% | 5.00% | 4.00% | 4.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
| Profit Before Tax | 0 | 2 | 1 | 1 | 2 | 2 | 1 |
| Tax | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 2 | 1 | 1 | 1 | 1 | 1 |
| Earnings Per Share (₹) | 0.00 | 4.02 | 2.57 | 2.49 | 3.61 | 3.96 | 2.69 |
SAROJA Balance Sheet — Assets, Liabilities & Shareholders' Equity
SAROJA total assets ₹42 Cr, total equity ₹17 Cr, total liabilities ₹ Cr (2026) — ROE 11.8%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Total Assets | 42 | 40 | 27 | 21 | 16 | 8 |
| Current Assets | 19 | 27 | 18 | 16 | 15 | 8 |
| Fixed Assets | 23 | 3 | 3 | 2 | 0 | 0 |
| Capital Work in Progress | 20 | 9 | 6 | 2 | 0 | 0 |
| Investments | 1 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 28 | 18 | 17 | 15 | 8 |
| LIABILITIES | ||||||
| Total Liabilities | ||||||
| Current Liabilities | 7 | 1 | 3 | 3 | 2 | 1 |
| Non-Current Liabilities | ||||||
| SHAREHOLDERS' EQUITY | ||||||
| Total Equity | 17 | 16 | 15 | 5 | 4 | 1 |
| Share Capital | 4 | 4 | 4 | 3 | 0 | 0 |
| Reserves & Surplus | 13 | 12 | 11 | 2 | 4 | 1 |
SAROJA Cash Flow Statement — Operating, Investing & Financing
Saroja Pharma Industries operating cash flow ₹1 Cr, investing ₹-3 Cr, financing ₹2 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|
| Operating Activities | 1 | 1 | 2 | -4 | -1 |
| Investing Activities | -3 | -5 | -5 | 0 | 0 |
| Financing Activities | 2 | 4 | 3 | 4 | 1 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 |